HopeStage
Back to all studies
TerminatedNCT01040338

Effects of Nicotine on Brain Opioid Receptors

Observational studyAges 18–50United StatesAddiction
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 50 years.

Listed locations
PhiladelphiaSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateFebruary 2010
Recruitment status
Terminated
Enrollment listed in the registry
15
Sponsor
University of Pennsylvania
Sponsor type
University
Study type
Observational
Intervention type
Drug
Locations
United States
Age range
From 18 Years to 50 Years
Official registry ID
NCT01040338
Official title
Show the full official title

Functional Characterization of OPRM1 A118G in Nicotine Dependence: IV Nicotine Study

Recruitment & locations

Terminated

Philadelphia

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is University of Pennsylvania, a university.

Does this study involve medication?

Yes. The study involves medication, including Nicotine.

Who can participate?

Listed age limits: 18 years to 50 years.

Is this study still recruiting?

The registry lists this study as terminated.

Want to explore more studies?

Explore studies